CORE MOLDING TECHNOLOGIES IN (CMT) Stock Fundamental Analysis
NYSEARCA:CMT - NYSE Arca - US2186831002 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to CMT. CMT was compared to 85 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making CMT a very profitable company, without any liquidiy or solvency issues. A decent growth rate in combination with a cheap valuation! Better keep an eye on CMT. This makes CMT very considerable for value investing!
1. Profitability
1.1 Basic Checks
CMT had positive earnings in the past year.
In the past year CMT had a positive cash flow from operations.
CMT had positive earnings in each of the past 5 years.
CMT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CMT has a better Return On Assets (6.35%) than 87.06% of its industry peers.
The Return On Equity of CMT (9.02%) is better than 71.76% of its industry peers.
The Return On Invested Capital of CMT (7.49%) is better than 71.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CMT is above the industry average of 7.10%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.35% | ||
| ROE | 9.02% | ||
| ROIC | 7.49% |
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
1.3 Margins
CMT's Profit Margin of 4.40% is fine compared to the rest of the industry. CMT outperforms 61.18% of its industry peers.
CMT's Profit Margin has improved in the last couple of years.
The Operating Margin of CMT (5.52%) is worse than 62.35% of its industry peers.
In the last couple of years the Operating Margin of CMT has grown nicely.
CMT has a Gross Margin of 17.61%. This is in the lower half of the industry: CMT underperforms 70.59% of its industry peers.
CMT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.52% | ||
| PM (TTM) | 4.4% | ||
| GM | 17.61% |
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CMT is still creating some value.
CMT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CMT has been increased compared to 5 years ago.
Compared to 1 year ago, CMT has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.32 indicates that CMT is not in any danger for bankruptcy at the moment.
CMT's Altman-Z score of 4.32 is amongst the best of the industry. CMT outperforms 89.41% of its industry peers.
The Debt to FCF ratio of CMT is 0.91, which is an excellent value as it means it would take CMT, only 0.91 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CMT (0.91) is better than 96.47% of its industry peers.
CMT has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.13, CMT belongs to the best of the industry, outperforming 83.53% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.91 | ||
| Altman-Z | 4.32 |
ROIC/WACC0.9
WACC8.33%
2.3 Liquidity
CMT has a Current Ratio of 2.80. This indicates that CMT is financially healthy and has no problem in meeting its short term obligations.
CMT has a better Current ratio (2.80) than 82.35% of its industry peers.
A Quick Ratio of 2.30 indicates that CMT has no problem at all paying its short term obligations.
CMT's Quick ratio of 2.30 is amongst the best of the industry. CMT outperforms 85.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.8 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
CMT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.32%.
Measured over the past years, CMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.08% on average per year.
The Revenue for CMT has decreased by -33.87% in the past year. This is quite bad
The Revenue has been growing slightly by 1.24% on average over the past years.
EPS 1Y (TTM)-35.32%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-33.87%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-15.29%
3.2 Future
Based on estimates for the next years, CMT will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.57% on average per year.
The Revenue is expected to grow by 1.48% on average over the next years.
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.31%
Revenue Next 2Y1.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.12, the valuation of CMT can be described as very reasonable.
Based on the Price/Earnings ratio, CMT is valued cheaply inside the industry as 85.88% of the companies are valued more expensively.
CMT is valuated cheaply when we compare the Price/Earnings ratio to 28.88, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.85, the valuation of CMT can be described as reasonable.
Based on the Price/Forward Earnings ratio, CMT is valued cheaper than 83.53% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.20. CMT is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.12 | ||
| Fwd PE | 8.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CMT is valued cheaply inside the industry as 95.29% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CMT is valued cheaply inside the industry as 92.94% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.03 | ||
| EV/EBITDA | 3.91 |
4.3 Compensation for Growth
CMT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CMT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y10.57%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CMT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
15.38
+0.47 (+3.15%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners68.22%
Inst Owner Change-0.88%
Ins Owners8.01%
Ins Owner Change3.37%
Market Cap142.42M
Analysts80
Price Target22.44 (45.9%)
Short Float %2.82%
Short Ratio6.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.51%
Min EPS beat(2)-100%
Max EPS beat(2)54.97%
EPS beat(4)3
Avg EPS beat(4)22.7%
Min EPS beat(4)-100%
Max EPS beat(4)72.09%
EPS beat(8)6
Avg EPS beat(8)73.52%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.12%
Min Revenue beat(2)0.98%
Max Revenue beat(2)5.25%
Revenue beat(4)3
Avg Revenue beat(4)4.35%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)11.57%
Revenue beat(8)5
Avg Revenue beat(8)2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.59%
Revenue NY rev (1m)5.95%
Revenue NY rev (3m)5.95%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.12 | ||
| Fwd PE | 8.85 | ||
| P/S | 0.47 | ||
| P/FCF | 6.03 | ||
| P/OCF | 4.05 | ||
| P/B | 0.97 | ||
| P/tB | 1.13 | ||
| EV/EBITDA | 3.91 |
EPS(TTM)1.52
EY9.88%
EPS(NY)1.74
Fwd EY11.3%
FCF(TTM)2.55
FCFY16.59%
OCF(TTM)3.8
OCFY24.68%
SpS32.65
BVpS15.91
TBVpS13.56
PEG (NY)0.71
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.35% | ||
| ROE | 9.02% | ||
| ROCE | 9.66% | ||
| ROIC | 7.49% | ||
| ROICexc | 9.88% | ||
| ROICexgc | 11.85% | ||
| OM | 5.52% | ||
| PM (TTM) | 4.4% | ||
| GM | 17.61% | ||
| FCFM | 7.81% |
ROA(3y)7.3%
ROA(5y)5.79%
ROE(3y)11.32%
ROE(5y)9.32%
ROIC(3y)9.78%
ROIC(5y)8.36%
ROICexc(3y)11.4%
ROICexc(5y)9.43%
ROICexgc(3y)13.69%
ROICexgc(5y)11.53%
ROCE(3y)12.62%
ROCE(5y)10.78%
ROICexcg growth 3Y14.36%
ROICexcg growth 5YN/A
ROICexc growth 3Y16.49%
ROICexc growth 5YN/A
OM growth 3Y18.22%
OM growth 5YN/A
PM growth 3Y44.97%
PM growth 5YN/A
GM growth 3Y9.42%
GM growth 5Y18.42%
F-Score6
Asset Turnover1.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.91 | ||
| Debt/EBITDA | 0.65 | ||
| Cap/Depr | 86.01% | ||
| Cap/Sales | 3.81% | ||
| Interest Coverage | 15.55 | ||
| Cash Conversion | 116.8% | ||
| Profit Quality | 177.65% | ||
| Current Ratio | 2.8 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z | 4.32 |
F-Score6
WACC8.33%
ROIC/WACC0.9
Cap/Depr(3y)98.69%
Cap/Depr(5y)85.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.23%
Profit Quality(3y)108.24%
Profit Quality(5y)132.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-35.32%
EPS 3Y40.08%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y14.29%
EPS Next 2Y10.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.87%
Revenue growth 3Y-0.56%
Revenue growth 5Y1.24%
Sales Q2Q%-15.29%
Revenue Next Year1.31%
Revenue Next 2Y1.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-51.76%
EBIT growth 3Y17.56%
EBIT growth 5YN/A
EBIT Next Year121.88%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.22%
FCF growth 3Y189.18%
FCF growth 5Y20.65%
OCF growth 1Y0.89%
OCF growth 3Y40.98%
OCF growth 5Y16.05%